About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Head and neck cancer is an understudied disease with a high relapse and mortality rate. Therapeutic modalities have not significantly improved since the last 40 years. Even though immunotherapy is providing promising results, currently it is only applicable to metastatic patients. Finding new therapies for HNSCC patients is the main objective and challenge for basic and clinical researchers. With the idea of promoting new challenges and future applications for medium term applicability to HNSCC patients.
December 2nd
09.00 h Benvinguda
Juan Pablo Rodrigo (University Professor, Department of Otorhinolaryngology, Universidad de Oviedo)
Amancio Carnero Moya (Head of Lab Biomedical Institute of Sevilla (IBIS/CSIC)
Coffee break
Eduardo Dominguez (Senior reseacher, Universidad de Santiago de Compostela)
Pablo Vergés Fort (Assistant Doctor Otolaryngology Department HUVH)
Diego Arango (Director of the Institut de Recerca Biomèdica CREBA, LLeida)
Irene Braña (Medical oncologist of the Head and Neck Cancer Tumour Group VHIO)
Lunch break
Marina Bataller (Researcher in the Biomedical research in cancer stem cells Group, VHIR)
Katerin Rojas (Medical oncologist of the Head and Neck Cancer Tumour Group VHIO)
Germaine Escames Rosa (Professor of Physiology Biomedical Research Centre, Universidad de Granada)
David Virós Porcuna (Head of Otorhinolaryngology Department HUVH)
Giovanni Blandino (Translation Research Coordinator CTC IFO/IRE; IRCCS Regina Elena National Cancer Institute, Italy)
Beatriz Cirauqui (Medical Oncologist, Institut Català d'Oncologia- Badalona)
Francisco José Hermida Prado (Senior reseacher, Department of Otorhinolaryngology, Universidad de Oviedo
December 3rd
Francesc Xavier Avilés (Clinical researcher, Hospital Clínic de Barcelona)
Salvador Aznar (ICREA Research Professor and Group leader, Institute for Research in Biomedicine; IRB Barcelona)
Santiago Ramón y Cajal (HUVH) (Professor, Pathology Department)
Matilde E. LLeonart (Vall d´Hebron Research Institute. Barcelona)
Xavier León Vintró (Clinical researcher, Hospital de la Santa Creu i Sant Pau. Barcelona)
Ángel Carracedo Alvarez (Professor, Universidad de Santiago de Compostela)
Thematic round tables